Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke Patients with History of Prior Stroke Plus Diabetes

BACKGROUND AND PURPOSE: Acute ischemic stroke (AIS) patients with history of prior ischemic stroke plus concomitant diabetes mellitus (DM) were excluded from the ECASS III trial due to safety concerns. However, there are few data on use of intravenous tissue plasminogen activator (tPA) and symptomat...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Stroke
Prif Awduron: Ehrlich, Matthew E., Liang, Li, Xu, Haolin, Kosinski, Andrzej S., Hernandez, Adrian F., Schwamm, Lee H., Smith, Eric E., Fonarow, Gregg C., Bhatt, Deepak L., Peterson, Eric D., Xian, Ying
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2019
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6538420/
https://ncbi.nlm.nih.gov/pubmed/31035901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.118.024172
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg